In animal models, treated glioma cells resulted in more immunosuppressive than untreated samples as a consequence of the impressive overexpression of immunosuppressive cytokines including IL-4, IL-10, IL-6 and GM-CSF [69]. This evidence concerns the gene CSF2 and central nervous system cancer.